Boston Scientific (BSX) Shares Outstanding (2009 - 2026)

Boston Scientific (BSX) has 18 years of Shares Outstanding (Entity) data on file, last reported at $1.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) fell 14.7% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (down 14.7% YoY), and the FY2025 full-year result was $1.7 billion, changed 0.49% from the prior year.
• Shares Outstanding (Entity) fell to $1.5 billion in Q1 2026, from $1.7 billion in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $1.7 billion in Q4 2025 to a low of $1.5 billion in Q1 2024.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) declined 14.72% in 2024 and increased 18.52% in 2025, its largest moves.
• Tracing BSX's Shares Outstanding (Entity) over 5 years: stood at $1.7 billion in 2022, then increased by 1.91% to $1.7 billion in 2023, then rose by 0.51% to $1.7 billion in 2024, then rose by 0.49% to $1.7 billion in 2025, then retreated by 14.88% to $1.5 billion in 2026.
• Business Quant data shows BSX's Shares Outstanding (Entity) at $1.5 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.7 billion in Q3 2025.